Biogen Idec opens new RTP facility
29 November 2012 | By Biogen Idec
Biogen Idec dedicated a new facility in Research Triangle Park (RTP), consolidating its 300-person Patient Services operation with the existing RTP campus...
List view / Grid view
29 November 2012 | By Biogen Idec
Biogen Idec dedicated a new facility in Research Triangle Park (RTP), consolidating its 300-person Patient Services operation with the existing RTP campus...
29 November 2012 | By Virgo HEALTH
NextPharma Technologies Holding Limited is pleased to announce the sale of Bioserv Corporation...
28 November 2012 | By Citigate Dewe Rogerson Ltd
Genzyme appointed Brendan Martin as General Manager for UK and Ireland...
28 November 2012 | By Sanofi
Sanofi ranked third among twenty pharmaceutical companies on the 2012 Access to Medicine Index (ATM Index)...
28 November 2012 | By Novartis
More than 140 presentations on key data...
28 November 2012 | By GlaxoSmithKline
GSK welcomes the publication of the third Access to Medicines (ATM) Index...
28 November 2012 | By Catalent Pharma Solutions
Jeffrey E. Browne at Catalent Pharma Solutions will be presenting...
28 November 2012 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of NextWave Pharmaceuticals, Inc..
28 November 2012 | By Abbott
Abbott board of directors approved the separation of its research-based pharmaceuticals business...
27 November 2012 | By kdm communications limited
Tecan has developed an AlphaScreen® module for its popular Infinite® F200 PRO multimode reader...
27 November 2012 | By kdm communications limited
LoGiCal® reference materials from LGC Standards have enabled Spark Holland to establish an online SPE-LC/MSMS method...
27 November 2012 | By Novo Nordisk
New data analyses...
27 November 2012 | By Abbott
Abbott announced that the European Commission has approved HUMIRA®...
27 November 2012 | By Gilead Sciences, Inc.
Gilead Sciences announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread®...
27 November 2012 | By Merck
Novel personalized treatment approach targets folate receptors on cancer cells...